search
Back to results

Ketamine Use in Electroconvulsive Therapy

Primary Purpose

Depression

Status
Withdrawn
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
ECT + Ketamine
Sponsored by
Hospital de Clinicas de Porto Alegre
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Depression

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion criteria

- Patients with unipolar and bipolar depression from The Psychiatric Unit of Hospital de Clinicas de Porto Alegre (diagnosis will be established by the Structured Clinical Interview for DSM-IV Axis I)

Exclusion criteria:

  • Patients with dementia
  • History of addiction / abuse of psychoactive drugs
  • Other psychiatric diagnoses
  • Refusal to follow the study.

Sites / Locations

  • Federal University of Rio Grande do Sul / Hospital de Clínicas de Porto Alegre (HCPA)

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Experimental

Arm Label

ECT + saline

ECT + Ketamine

Arm Description

Brief pulse ECT with saline as placebo in each session

Brief pulse ECT with 0.05 mg/kg ketamine infusion in each session

Outcomes

Primary Outcome Measures

Hamilton Depression Scale (HAM-D) 17 change

Secondary Outcome Measures

Mini Mental Status Exam change
Autobiographical Memory Test change
Rey Auditory Verbal Learning Test change
WAIS Digit Span change
FAS verbal fluency change
Stroop Test change
Trial Making Test change
WAIS Vocabulary
Montgomery and Asberg Depression Rating Scale change
Brief Psychiatry Rating Scale change
Clinical Global Impression-Severity change

Full Information

First Posted
November 18, 2013
Last Updated
March 18, 2015
Sponsor
Hospital de Clinicas de Porto Alegre
search

1. Study Identification

Unique Protocol Identification Number
NCT02012335
Brief Title
Ketamine Use in Electroconvulsive Therapy
Official Title
Ketamine Use in Electroconvulsive Therapy: Clinical, Cognitives and Neurotrophic Outcomes
Study Type
Interventional

2. Study Status

Record Verification Date
March 2015
Overall Recruitment Status
Withdrawn
Why Stopped
Methodologicals and logistics issues.
Study Start Date
January 2014 (undefined)
Primary Completion Date
January 2016 (Anticipated)
Study Completion Date
January 2016 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospital de Clinicas de Porto Alegre

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine whether combination of ketamine plus electroconvulsive therapy improves depressive symptoms decreasing cognitive side effects.
Detailed Description
This study will compare the clinical response to brief pulse ECT with infusion of ketamine 0.5 mg/kg versus brief pulse electroconvulsive therapy with infusion of placebo (saline) in major depression. We also will compare levels of cognitive impairment among these groups, compare levels of quality of life among these groups, compare levels of BDNF among these groups. We also will study if levels of 25-hydroxyvitamin D are associated with cognitive impairment in subjects undergoing ECT.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
ECT + saline
Arm Type
Placebo Comparator
Arm Description
Brief pulse ECT with saline as placebo in each session
Arm Title
ECT + Ketamine
Arm Type
Experimental
Arm Description
Brief pulse ECT with 0.05 mg/kg ketamine infusion in each session
Intervention Type
Drug
Intervention Name(s)
ECT + Ketamine
Intervention Description
Brief pulse ECT with 0.05 mg/kg ketamine infusion in each session
Primary Outcome Measure Information:
Title
Hamilton Depression Scale (HAM-D) 17 change
Time Frame
Baseline, week 1, week 2, week 3, week 4, and at the end of hospital stay, an expected average of 5 weeks
Secondary Outcome Measure Information:
Title
Mini Mental Status Exam change
Time Frame
Baseline and at the end of hospital stay, an expected average of 5 weeks
Title
Autobiographical Memory Test change
Time Frame
Baseline and at the end of hospital stay, an expected average of 5 weeks
Title
Rey Auditory Verbal Learning Test change
Time Frame
Baseline and at the end of hospital stay, an expected average of 5 weeks
Title
WAIS Digit Span change
Time Frame
Baseline and at the end of hospital stay, an expected average of 5 weeks
Title
FAS verbal fluency change
Time Frame
Baseline and at the end of hospital stay, an expected average of 5 weeks
Title
Stroop Test change
Time Frame
Baseline and at the end of hospital stay, an expected average of 5 weeks
Title
Trial Making Test change
Time Frame
Baseline and at the end of hospital stay, an expected average of 5 weeks
Title
WAIS Vocabulary
Time Frame
Baseline
Title
Montgomery and Asberg Depression Rating Scale change
Time Frame
Baseline, week 1, week 2, week 3, week 4, and at the end of hospital stay, an expected average of 5 weeks
Title
Brief Psychiatry Rating Scale change
Time Frame
Baseline, week 1, week 2, week 3, week 4, and at the end of hospital stay, an expected average of 5 weeks
Title
Clinical Global Impression-Severity change
Time Frame
Baseline, week 1, week 2, week 3, week 4, and at the end of hospital stay, an expected average of 5 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria - Patients with unipolar and bipolar depression from The Psychiatric Unit of Hospital de Clinicas de Porto Alegre (diagnosis will be established by the Structured Clinical Interview for DSM-IV Axis I) Exclusion criteria: Patients with dementia History of addiction / abuse of psychoactive drugs Other psychiatric diagnoses Refusal to follow the study.
Facility Information:
Facility Name
Federal University of Rio Grande do Sul / Hospital de Clínicas de Porto Alegre (HCPA)
City
Porto Alegre
State/Province
RS
ZIP/Postal Code
90035-003
Country
Brazil

12. IPD Sharing Statement

Learn more about this trial

Ketamine Use in Electroconvulsive Therapy

We'll reach out to this number within 24 hrs